Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2001 1
2003 1
2007 1
2008 1
2012 2
2015 1
2016 1
2017 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Nasal Nitric Oxide as a Biomarker in the Diagnosis and Treatment of Sinonasal Inflammatory Diseases: A Review of the Literature.
Benedict JJ, Lelegren M, Han JK, Lam K. Benedict JJ, et al. Ann Otol Rhinol Laryngol. 2023 Apr;132(4):460-469. doi: 10.1177/00034894221093890. Epub 2022 May 12. Ann Otol Rhinol Laryngol. 2023. PMID: 35549446 Review.
OBJECTIVE: To critically review the literature on nasal nitric oxide (nNO) and its current clinical and research applicability in the diagnosis and treatment of different sinonasal inflammatory diseases, including acute bacterial rhinosinusitis (ABRS), allerg …
OBJECTIVE: To critically review the literature on nasal nitric oxide (nNO) and its current clinical and research applic …
Management of primary ciliary dyskinesia in European children: recommendations and clinical practice.
Strippoli MP, Frischer T, Barbato A, Snijders D, Maurer E, Lucas JS, Eber E, Karadag B, Pohunek P, Zivkovic Z, Escribano A, O'Callaghan C, Bush A, Kuehni CE; ERS Task Force onPrimary Ciliary Dyskinesia in Children. Strippoli MP, et al. Eur Respir J. 2012 Jun;39(6):1482-91. doi: 10.1183/09031936.00073911. Epub 2012 Jan 26. Eur Respir J. 2012. PMID: 22282549 Free article.
Overall, 90% of centres had access to nasal or bronchial mucosal biopsy. Samples were analysed by electron microscopy (77%) and ciliary function tests (57%). Nasal nitric oxide was used for screening in 46% of centres and saccharine tests in 36%. ...
Overall, 90% of centres had access to nasal or bronchial mucosal biopsy. Samples were analysed by electron microscopy (77%) and cilia …
Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.
Goldenberg MM. Goldenberg MM. Clin Ther. 1998 Nov-Dec;20(6):1033-48. doi: 10.1016/s0149-2918(98)80103-3. Clin Ther. 1998. PMID: 9916601 Free article. Review.
Sildenafil has no direct relaxant effect on human corpus cavernosum but enhances the relaxant effect of nitric oxide (NO) on the corpus cavernosum by inhibiting PDE5, which is responsible for degradation of cGMP in this tissue. ...Adverse effects reported at a rate …
Sildenafil has no direct relaxant effect on human corpus cavernosum but enhances the relaxant effect of nitric oxide (NO) on t …
Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.
Sahni R, Ameer X, Ohira-Kist K, Wung JT. Sahni R, et al. J Perinatol. 2017 Jan;37(1):54-60. doi: 10.1038/jp.2016.164. Epub 2016 Oct 6. J Perinatol. 2017. PMID: 27711045
OBJECTIVES: Inhaled nitric oxide (iNO) is effective in conjunction with tracheal intubation (TI) and mechanical ventilation (MV) for treating arterial pulmonary hypertension and hypoxemic respiratory failure (HRF) in near-term and term newborns. ...Analysis of envir …
OBJECTIVES: Inhaled nitric oxide (iNO) is effective in conjunction with tracheal intubation (TI) and mechanical ventilation (M …
Associations of short-term PM(2.5) exposures with nasal oxidative stress, inflammation and lung function impairment and modification by GSTT1-null genotype: A panel study of the retired adults.
Sun B, Song J, Wang Y, Jiang J, An Z, Li J, Zhang Y, Wang G, Li H, Alexis NE, Jaspers I, Wu W. Sun B, et al. Environ Pollut. 2021 Sep 15;285:117215. doi: 10.1016/j.envpol.2021.117215. Epub 2021 Apr 24. Environ Pollut. 2021. PMID: 33932759 Free article.
Pulmonary outcomes including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV(1)), peak expiratory flow (PEF), and fractional exhaled nitric oxide (FeNO), and nasal fluid concentrations of 8-epi-prostaglandin F2 alpha (8-epi-PGF2alpha), tumor …
Pulmonary outcomes including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV(1)), peak expiratory flow (PEF), and fraction …
Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment.
Lavie L, Hefetz A, Luboshitzky R, Lavie P. Lavie L, et al. J Mol Neurosci. 2003;21(1):57-63. doi: 10.1385/JMN:21:1:57. J Mol Neurosci. 2003. PMID: 14500996
Sleep apnea syndrome has been shown to be associated with decreased levels of circulating nitric oxide (NO) after waking up from sleep. In this study we investigated overnight plasma concentrations of NO in sleep apnea patients before and after nasal c …
Sleep apnea syndrome has been shown to be associated with decreased levels of circulating nitric oxide (NO) after wakin …
High-altitude treatment in atopic and nonatopic patients with severe asthma.
Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH, Weersink EJ. Rijssenbeek-Nouwens LH, et al. Eur Respir J. 2012 Dec;40(6):1374-80. doi: 10.1183/09031936.00195211. Epub 2012 Mar 22. Eur Respir J. 2012. PMID: 22441741 Free article.
We measured asthma control (Asthma Control Questionnaire (ACQ)), asthma-related quality of life (Asthma-Related Quality of Life Questionnaire (AQLQ)), sino-nasal symptoms (Sino-Nasal Outcome Test (SNOT-20)), medication requirement, postbronchodilator (post-BD) force …
We measured asthma control (Asthma Control Questionnaire (ACQ)), asthma-related quality of life (Asthma-Related Quality of Life Questionnair …
Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release.
Lattimore JD, Wilcox I, Adams MR, Kilian JG, Celermajer DS. Lattimore JD, et al. Int J Cardiol. 2008 May 23;126(2):229-33. doi: 10.1016/j.ijcard.2007.04.001. Epub 2007 Jun 29. Int J Cardiol. 2008. PMID: 17604137
RESULTS: At baseline, pulmonary flow increased in response to acetylcholine and nitroprusside and fell in response to l-NMMA. Following CPAP treatment, the decrease in flow to l-NMMA was significantly greater (to 62+/-6% of control value vs 85+/-6% of pre-treatment; p=0.01 …
RESULTS: At baseline, pulmonary flow increased in response to acetylcholine and nitroprusside and fell in response to l-NMMA. Following CPAP …
An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis.
Jardeleza C, Thierry B, Rao S, Rajiv S, Drilling A, Miljkovic D, Paramasivan S, James C, Dong D, Thomas N, Vreugde S, Prestidge CA, Wormald PJ. Jardeleza C, et al. Transl Res. 2015 Dec;166(6):683-92. doi: 10.1016/j.trsl.2015.06.009. Epub 2015 Jun 24. Transl Res. 2015. PMID: 26166254
This underpins the importance of discovering alternatives to current antibiotic regimens. In chronic rhinosinusitis (CRS), topical therapy such as nasal douches and steroid sprays is the mainstay of treatment. ...Nitric oxide (NO), an endogenous antimi …
This underpins the importance of discovering alternatives to current antibiotic regimens. In chronic rhinosinusitis (CRS), topical therap …
Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests.
Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. Channick RN, et al. Chest. 1996 Jun;109(6):1545-9. doi: 10.1378/chest.109.6.1545. Chest. 1996. PMID: 8769509
BACKGROUND: Inhaled nitric oxide (NO) has been shown to be a selective pulmonary vasodilator in certain patients with primary pulmonary hypertension (PPH). ...Three of the eight patients had both greater than 20% and greater than 30% decreases in PAPm and PVR …
BACKGROUND: Inhaled nitric oxide (NO) has been shown to be a selective pulmonary vasodilator in certain patients with primary …
11 results